Health Adcytherix Secures €104 Million Series A Funding for ADC Drug A French biotechnology company, Adcytherix, has successfully raised €104 million in a Series A funding round aimed at advancing its innovative antibody-drug conjugate (ADC)... Editorial16 October, 2025